German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
Standard
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. / Hoffmann, Jürgen; Souchon, Rainer; Lebeau, Annette; Öhlschlegel, Christian; Gruber, Günther; Rageth, Christoph; Weber, Walter; Harbeck, Nadia; Janni, Wolfgang; Kreipe, Hans; Fitzal, Florian; Resch, Alexandra; Bago-Horvath, Zsuzsanna; Peintinger, Florentia; AGO.
in: EUR J CANCER, Jahrgang 49, Nr. 10, 01.07.2013, S. 2277-83.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
AU - Hoffmann, Jürgen
AU - Souchon, Rainer
AU - Lebeau, Annette
AU - Öhlschlegel, Christian
AU - Gruber, Günther
AU - Rageth, Christoph
AU - Weber, Walter
AU - Harbeck, Nadia
AU - Janni, Wolfgang
AU - Kreipe, Hans
AU - Fitzal, Florian
AU - Resch, Alexandra
AU - Bago-Horvath, Zsuzsanna
AU - Peintinger, Florentia
AU - AGO
N1 - Copyright © 2013 Elsevier Ltd. All rights reserved.
PY - 2013/7/1
Y1 - 2013/7/1
N2 - The German, Austrian and Swiss (D.A.CH) Societies of Senology gathered together in 2012 to address dwelling questions regarding axillary clearance in breast cancer patients. The Consensus Panel consisted of 14 members of these societies and included surgical oncologists, gynaecologists, pathologists and radiotherapists. With regard to omitting axillary lymph node dissection in sentinel lymph node macrometastases, the Panel consensually accepted this option for low-risk patients only. A simple majority voted against extending radiotherapy to the axilla after omitting axillary dissection in N1 disease. Consensus was yielded for the use of axillary ultrasound and prospective registers for such patients in the course of follow-up. The questions regarding neoadjuvant therapy and the timing of sentinel lymph node biopsy failed to yield consensus, yet both options (before or after) are possible in clinically node-negative disease.
AB - The German, Austrian and Swiss (D.A.CH) Societies of Senology gathered together in 2012 to address dwelling questions regarding axillary clearance in breast cancer patients. The Consensus Panel consisted of 14 members of these societies and included surgical oncologists, gynaecologists, pathologists and radiotherapists. With regard to omitting axillary lymph node dissection in sentinel lymph node macrometastases, the Panel consensually accepted this option for low-risk patients only. A simple majority voted against extending radiotherapy to the axilla after omitting axillary dissection in N1 disease. Consensus was yielded for the use of axillary ultrasound and prospective registers for such patients in the course of follow-up. The questions regarding neoadjuvant therapy and the timing of sentinel lymph node biopsy failed to yield consensus, yet both options (before or after) are possible in clinically node-negative disease.
KW - Austria
KW - Axilla
KW - Breast Neoplasms
KW - Female
KW - Germany
KW - Humans
KW - Lymph Node Excision
KW - Lymphatic Metastasis
KW - Neoadjuvant Therapy
KW - Sentinel Lymph Node Biopsy
KW - Switzerland
U2 - 10.1016/j.ejca.2013.01.034
DO - 10.1016/j.ejca.2013.01.034
M3 - SCORING: Journal article
C2 - 23490652
VL - 49
SP - 2277
EP - 2283
JO - EUR J CANCER
JF - EUR J CANCER
SN - 0959-8049
IS - 10
ER -